Literature DB >> 10227802

Frequency of vaccine-related and therapeutic injections--Romania, 1998.

.   

Abstract

In Romania and other countries, therapeutic injections have been associated with transmission of hepatitis B and C viruses, human immunodeficiency virus type 1 (HIV-1), and other bloodborne pathogens. During 1997-1998, acute hepatitis B was associated with recent injections in Romanian children aged <5 years. Injection-associated bloodborne pathogen transmission occurs when infection-control practices are inadequate, and overuse of injections to administer medications might increase opportunities for transmission. To estimate the frequency of therapeutic injections and to describe the attitudes and practices of adults about injections to administer medications, local health departments in Romania surveyed the general population of four districts (Hunedoara, Iasi, Mures, and Prahova [1997 combined population: 2.8 million]) in June 1998. This report summarizes results from these surveys, which indicate that injections are used frequently to administer medications in Romania.

Entities:  

Mesh:

Year:  1999        PMID: 10227802

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

Review 1.  Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates.

Authors:  Yvan J F Hutin; Anja M Hauri; Gregory L Armstrong
Journal:  BMJ       Date:  2003-11-08

2.  High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection.

Authors:  Simona Maria Ruta; Rodica Floarea Matusa; Camelia Sultana; Loredana Manolescu; Claudia A Kozinetz; Mark W Kline; Costin Cernescu
Journal:  MedGenMed       Date:  2005-03-28

3.  High prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection.

Authors:  Simona Maria Ruta; Rodica Floarea Matusa; Camelia Sultana; Loredana Manolescu; Claudia A Kozinetz; Mark W Kline; Costin Cernescu
Journal:  J Int AIDS Soc       Date:  2005-03-25       Impact factor: 5.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.